The plasticity of germ cell cancers and its dependence on the cellular microenvironment-Reference-Cited by-同舟云学术

The plasticity of germ cell cancers and its dependence on the cellular microenvironment

Published:2017-02-28 Issue:8 Volume:21 Page:1463-1467
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Nettersheim Daniel¹,Schorle Hubert¹

Affiliation:

1. Department of Developmental Pathology; Institute of Pathology; University Medical School; Bonn Germany

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcmm.13082/fullpdf

Reference51 articles.

1. Possible carcinoma-in-situ of the testis;Skakkebaek;Lancet,1972

2. Identification of genes differentially expressed in testes containing carcinoma in situ;Hoei-Hansen;Mol Hum Reprod,2004

3. Testicular germ-cell tumours in a broader perspective;Oosterhuis;Nat Rev Cancer,2005

4. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors;Biermann;Cancer Genomics Proteomics,2007

5. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte;Sonne;Cancer Res,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages;Matrix Biology;2024-09

2. EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors;Andrology;2024-02-21

3. Administration of a glypican‐3 peptide increases the infiltration and cytotoxicity of CD8⁺ T cells against testicular yolk sac tumor, associated with enhancing the intratumoral cGAS/STING signaling;Cancer Medicine;2023-11-20

4. Testicular Mixed Teratoma and Yolk Sac Tumor, Prepubertal Type: A Case Report with Summary of Prior Published Cases;Fetal and Pediatric Pathology;2023-11-09

5. Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy;Frontiers in Oncology;2023-10-25